Now showing items 1-1 of 1

    • Identifying Targetable Liabilities in Ewing Sarcoma 

      Vallurupalli, Mounica (2014-07-07)
      Background: Despite multi-modality therapy, the majority of patients with metastatic or recurrent Ewing sarcoma (ES), the second most common pediatric bone malignancy, will die of their disease. ES tumors express aberrantly ...